Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Martin Lanzendoerfer is active.

Publication


Featured researches published by Martin Lanzendoerfer.


Journal of Biomolecular Structure & Dynamics | 2003

Comparative Analysis of Docking Motifs in MAP-Kinases and Nuclear Receptors

Elke Burgermeister; Martin Lanzendoerfer; Werner Scheuer

Abstract Nuclear receptor (NR) agonists induce activation of mitogen-activated protein kinases (MAPK) through an yet unknown rapid non-genomic mechanism. Vice versa, NR are targets for phosphorylation by MAPK. By multiple alignment of the amino acid sequences and comparative analysis of the secondary and tertiary structures we identified four peptides in MAPK with similarity to bona fide protein-protein-interaction motifs in NR. In both molecule species, these motifs mediate selective docking to dimerization partners, coregulators or phosphoacceptors. We therefore propose that similar motifs may direct the site-specific association of NR with MAPK. Based on mutual allosteric interactions within a kinase-receptor complex, we discuss a novel principle how NR-agonists may regulate kinase activity and thus expression of hormone-dependent genes.


Archive | 2005

Anti-OX40L Antibodies

Joseph Endl; Elsie M. Eugui; Maria E. Fuentes; Yvo Graus; Aran Frank Labrijn; Martin Lanzendoerfer; Paul Parren; Frank Rebers; Ralf Schumacher; Stefan Seeber; Jan van de Winkel; Martine van Vugt


Archive | 2011

Antibodies against human csf-1r and uses thereof

Nikolaos Dimoudis; Georg Fertig; Alexander Fidler; Klaus Kaluza; Marlene Thomas; Carola Ries; Stefan Seeber; Martin Lanzendoerfer


Archive | 2010

Antibodies binding preferentially human csf1r extracellular domain 4 and their use

Nikolaos Dimoudis; Georg Fertig; Alexander Fidler; Klaus Kaluza; Marlene Pickl; Carola Ries; Stefan Seeber; Martin Lanzendoerfer


Archive | 2004

Antibodies against interleukin-1 receptor and uses thereof

Ilse Bartke; Francis J. Carr; Richard Anthony Chizzonite; Elsie M. Eugui; Georg Fertig; Anita Hamilton; Martin Lanzendoerfer; Petra Rueger; Ralf Schumacher; Theresa Truitt


Archive | 2005

Conjugates of insulin-like growth factor-1 and poly(ethylene glycol)

Beat Amrein; Stefan Foser; Kurt Lang; Friedrich Metzger; Joerg Thomas Regula; Andreas Schaubmar; Friederike Hesse; Klaus-Peter Kuenkele; Martin Lanzendoerfer


Ejc Supplements | 2006

214 POSTER Characterization of a recombinant, fully human monoclonal antibody directed against the human insulin-like growth factor-1 receptor

T. Schnitzer; Klaus-Peter Kuenkele; Frank Rebers; M.J. van Vugt; C. Klein; Martin Lanzendoerfer; Olaf Mundigl; P.W.H.I. Parren; J. G. J. Van De Winkel; Ralf Schumacher


Archive | 2006

Hemopexin-like structure as polypeptide-scaffold

Martin Lanzendoerfer; Michael Schraeml


Archive | 2011

Method for an in vitro sequence specific biotinylation of polypeptides

Dorothee Ambrosius; Martin Lanzendoerfer; Michael Schraeml; Manfred Watzele


Archive | 2002

Method for sequence specific biotinylation

Dorothee Ambrosius; Martin Lanzendoerfer; Michael Schraeml; Manfred Watzele

Collaboration


Dive into the Martin Lanzendoerfer's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge